Total Payments
$9,504
2024 Payments
$2,028
Companies
31
Transactions
435
Medicare Patients
3,773
Medicare Billing
$263,566
Payment Breakdown by Category
Food & Beverage$9,404 (98.9%)
Education$99.99 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,404 | 434 | 98.9% |
| Education | $99.99 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,034 | 116 | $0 (2024) |
| GENZYME CORPORATION | $1,240 | 37 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $821.17 | 30 | $0 (2024) |
| Merz North America, Inc. | $593.01 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $497.10 | 22 | $0 (2024) |
| Lilly USA, LLC | $401.46 | 21 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $389.93 | 19 | $0 (2024) |
| Incyte Corporation | $382.05 | 17 | $0 (2024) |
| Galderma Laboratories, L.P. | $334.27 | 21 | $0 (2024) |
| LEO Pharma Inc. | $332.09 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,028 | 93 | ABBVIE INC. ($506.70) |
| 2023 | $2,750 | 115 | Merz North America, Inc. ($593.01) |
| 2022 | $1,753 | 77 | ABBVIE INC. ($403.16) |
| 2021 | $1,107 | 56 | AbbVie Inc. ($347.60) |
| 2020 | $133.68 | 8 | GENZYME CORPORATION ($35.38) |
| 2019 | $711.65 | 36 | Regeneron Healthcare Solutions, Inc. ($193.65) |
| 2018 | $780.69 | 42 | GENZYME CORPORATION ($233.36) |
| 2017 | $239.49 | 8 | Allergan Inc. ($170.16) |
All Payment Transactions
435 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.29 | General |
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.98 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.90 | General |
| 10/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.15 | General |
| Category: Immunology | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $33.16 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.92 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,608 | 2,552 | $384,793 | $107,129 |
| 2022 | 14 | 891 | 1,583 | $230,049 | $71,685 |
| 2021 | 11 | 671 | 1,223 | $158,223 | $51,735 |
| 2020 | 13 | 603 | 838 | $83,619 | $33,017 |
Total Patients
3,773
Total Services
6,196
Medicare Billing
$263,566
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 30 | 63 | $7,703 | $2,601 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $7,875 | $2,357 | 29.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 52 | 58 | $6,386 | $2,346 | 36.7% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 16 | 19 | $5,355 | $1,704 | 31.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 12 | 14 | $4,709 | $1,314 | 27.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 16 | 16 | $2,642 | $811.00 | 30.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 164 | 216 | $45,360 | $18,878 | 41.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 115 | 175 | $33,250 | $6,762 | 20.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 77 | 96 | $20,160 | $6,541 | 32.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 79 | $11,060 | $5,378 | 48.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 37 | 46 | $11,500 | $3,679 | 32.0% |
| 11300 | Shaving of 0.5 centimeters or less skin growth of the trunk, arms, or legs | Office | 2021 | 32 | 37 | $8,325 | $2,414 | 29.0% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 78 | 451 | $12,628 | $2,393 | 18.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 33 | 40 | $3,600 | $1,763 | 49.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 34 | 34 | $4,760 | $1,461 | 30.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $4,100 | $1,281 | 31.3% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 20 | 29 | $3,480 | $1,185 | 34.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 129 | 131 | $20,635 | $9,883 | 47.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 90 | 110 | $15,380 | $5,221 | 33.9% |
| 17000 | Destruction of skin growth | Office | 2020 | 111 | 120 | $11,990 | $4,450 | 37.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 64 | 67 | $8,705 | $4,157 | 47.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 23 | 25 | $4,240 | $1,894 | 44.7% |
| 11300 | Shaving of 0.5 centimeters or less skin growth of the trunk, arms, or legs | Office | 2020 | 18 | 22 | $2,565 | $1,540 | 60.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 25 | 25 | $4,400 | $1,372 | 31.2% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 72 | 242 | $6,874 | $1,088 | 15.8% |
About Dr. Corinne Erickson, MD
Dr. Corinne Erickson, MD is a Specialist healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1134321037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Corinne Erickson, MD has received a total of $9,504 in payments from pharmaceutical and medical device companies, with $2,028 received in 2024. These payments were reported across 435 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($9,404).
As a Medicare-enrolled provider, Erickson has provided services to 3,773 Medicare beneficiaries, totaling 6,196 services with total Medicare billing of $263,566. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Dermatology, Procedural Dermatology
- Location Atlanta, GA
- Active Since 06/03/2007
- Last Updated 06/24/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134321037
Products in Payments
- DUPIXENT (Biological) $1,300
- SKYRIZI (Biological) $874.28
- RINVOQ (Biological) $510.85
- OPZELURA (Drug) $382.05
- TREMFYA (Drug) $379.14
- TALTZ (Drug) $376.17
- EUCRISA (Drug) $326.34
- DUPIXENT (Drug) $286.91
- Sotyktu (Drug) $282.28
- HUMIRA (Biological) $269.73
- ADBRY (Biological) $228.11
- Humira (Biological) $227.64
- Otezla (Drug) $194.04
- Winlevi (Drug) $177.07
- AKLIEF (Drug) $135.24
- COSENTYX (Drug) $122.96
- REMICADE (Biological) $117.96
- COSENTYX (Biological) $116.04
- ENSTILAR (Drug) $103.98
- DUPIXENT DUPILUMAB INJECTION (Biological) $103.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Atlanta
Melhem Solh, M.d, M.D
Specialist — Payments: $1.1M
Specialist $1.1M
Sumayah Taliaferro, Md, MD
Specialist — Payments: $98,474
Specialist $98,474
Theresa Jarmuz, M.d, M.D
Specialist — Payments: $98,072
Specialist $98,072
Dr. Scott Solomon, M.d, M.D
Specialist — Payments: $59,894
Specialist $59,894
Dr. Asad Bashey, M.d, M.D
Specialist — Payments: $45,487
Specialist $45,487
Dr. Bronier Costas, M.d, M.D
Specialist — Payments: $45,325
Specialist $45,325